Did someone forward this to you? Subscribe to get updates and funding announcements directly in your inbox. | | | |
Apply Now for Translational Medicine and Value Assessment-Health Outcomes Research Awards
Deadline February 1
The PhRMA Foundation funds researchers conducting innovative work in value assessment and health outcomes research and translational medicine through predoctoral and postdoctoral fellowships and faculty research grants. Help spread the word about these funding opportunities!
| | | |
Read Before You Apply: Tips on Writing a Winning Application
Writing a fellowship or grant application can be intimidating — especially if you’re new at it. In a recent webinar, Peter J. Neumann, ScD, director of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center, shared his insights on applying for the Foundation's Value Assessment-Health Outcomes Research fellowships and grants. Be sure to check out his advice before you apply!
| |
| |
Foundation Announces New Board Members
The following leaders recently joined the Foundation's Board of Directors. Read the press release and view the complete Board list.
| | |
|
Aida Habtezion, MD
Chief Medical Officer, Pfizer
|
|
|
Maha Radhakrishnan, MD
Chief Medical Officer, Biogen
| | |
|
George Addona, PhD
SVP and Head of Discovery, Preclinical & Translational Medicine, Merck Research Laboratories
|
|
|
Lori Reilly, Esq
Chief Operating Officer, PhRMA
| | |
Foundation Awards $1.3M in Drug Discovery and Drug Delivery Fellowships and Grants
Congratulations to our 2023 award recipients in the areas of drug delivery and drug discovery. Out of nearly 300 applicants, the Foundation awarded 10 predoctoral students, four postdoctoral fellows, and four faculty starter grants. View the awardees.
| | |
Understanding the Role of Broader Value Elements in Value Assessment
The Center for Pharmaceutical Value (pValue), supported by the Foundation and headquartered at the University of Colorado Anschutz Medical Campus, conducts research on incorporating nontraditional value elements when assessing the value of a health care intervention. pValue recently held a workshop seeking to better understand how much weight should be given to broader contextual value elements that are relevant to all members of society, such as rarity and severity of disease, fear of contagion, and broader economic impact. Learn more.
|
| | |
|
“Innovators developing new health care interventions need some level of predictability in what value elements and data they need to capture in their studies so that we have the evidence we need later on to inform evidence-based deliberations and analyses for value assessment.”
— pValue Director R. Brett McQueen, PhD
|
| |
The Importance of Considering Patients’ Values and Opportunities in COVID-19 Vaccination Plans
Policy questions about vaccine research and eligibility requirements became kitchen-table conversations during the COVID-19 pandemic. But what factors are influencing whether individuals get vaccinated? Research by Foundation-funded scientists builds on the idea that it is ultimately a summation of patients’ values, beliefs, and circumstances that determine whether they will vaccinate. Read more.
| | |
Jonathan’s Story: A Passion for Drug Hunting
The Foundation is more than a grantmaking body for early-career researchers. We are a community bonded by a shared passion for advancing drug development. Jonathan Sockolosky, PhD, personifies this passion and is a great example of the type of researcher that our organization seeks to support. Learn about his career path.
| | |
Congrats to these Foundation-funded researchers on their recent work! |
| | | | |
